digital diabetes prevention program
Outcomes from the randomized controlled trial were presented today at a virtual conference. The company and its research partners say this study differs from others due to its size and length.
Omada Health's digital program was modified to better support the study's low-income, frequently Hispanic/Latino patient population.
Also: L’Oréal unveils UV sensor clip, companion app; Urinary incontinence wearable receives De Novo clearance.
Omada Health has made plans with the University of Nebraska Medical Center (UNMC) and Wake Forest University to conduct the largest randomized controlled study of a digital diabetes prevention tool yet, according to the digital therapeutic company.